Patent details
EP2347261
Title:
SELECTION OF COLORECTAL CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY
Basic Information
- Publication number:
- EP2347261
- PCT Application Number:
- PCT/US/2009/006267
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097958367
- PCT Publication Number:
- WO/2010/085234
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SELECTION OF COLORECTAL CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY
- French Title of Invention:
- SÉLECTION DE PATIENTS SOUFFRANT DE CANCERS COLORECTAUX EN VUE DE TRAITEMENTS PAR DES MÉDICAMENTS CIBLANT LA VOIE EGFR
- German Title of Invention:
- AUSWAHL VON PATIENTEN MIT KOLOREKTALKARZINOM FÜR EINE BEHANDLUNG MIT AUF DEN EGFR-WEG ZIELENDEN ARZNEISTOFFEN
- SPC Number:
-
Dates
- Filing date:
- 20/11/2009
- Grant date:
- 15/08/2012
- EP Publication Date:
- 15/08/2012
- PCT Publication Date:
- 29/07/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/07/2011
- EP B1 Publication Date:
- 15/08/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 20/11/2012
- Expiration date:
- 20/11/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/11/2009
-
-
- Name:
- Biodesix Inc.
- Address:
- 2790 Wilderness Place, Suite 100, Boulder, CO 80301, United States (US)
Inventor
1
- Name:
- GRIGORIEVA Julia
- Address:
- United States (US)
2
- Name:
- TSYPIN Maxim
- Address:
- United States (US)
3
- Name:
- RÖDER Heinrich
- Address:
- United States (US)
Priority
- Priority Number:
- 321394
- Priority Date:
- 20/01/2009
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
G01N 33/574;
Filing date |
Document type |
Number of pages |